Transforming Yeast into High-Performance Microbial Cell Factories for a Sustainable Future. Yeast species, particularly Saccharomyces cerevisiae and Yarrowia lipolytica, are the premier eukaryotic chassis for modern industrial biotechnology. CD Biosynsis provides professional Yeast Engineering Services, integrating cutting-edge toolkits such as enzyme directed evolution, organelle engineering, and Pareto-optimal metabolic modeling. We empower our clients to produce complex biofuels, pharmaceutical intermediates, and high-value bioactive ingredients with unprecedented efficiency and stability.
Get a Technical QuoteOur platform leverages the latest breakthroughs in synthetic biology to rewire yeast metabolism for maximum carbon flux redirection and industrial-scale fitness. We specialize in engineering both conventional and non-conventional yeast species through our Saccharomyces cerevisiae Genome Editing & Metabolic Engineering Solutions.
| Service Tier | Technical Strategy | Primary Application | Standard Deliverables |
|---|---|---|---|
| Biofuel Engineering | Enzyme directed evolution & Scaffolding | Biobutanol, Isoamyl alcohol, & Biofuels | Optimized strains + Yield analysis |
| Growth-Coupled Overproduction | Yeast Multi-gene Knockout | Sustainable organic acids & Chemicals | Coupled production strains + Stability data |
| Bioactive Material Processing | Surface display & Biotransformation | Skincare (Low-MW Hyaluronic Acid) | Activity-validated strains + Product profile |
| Recombinant Production | Yeast Protein Expression and Purification | Therapeutic Proteins & Enzymes | High-purity proteins + QC reports |
1. Metabolic Network Design
2. Genomic Rewiring
3. Enzyme & Pathway Optimization
4. Pilot-Scale Validation
Utilizing in silico modeling to identify bottlenecks and predict Pareto-optimal targets for growth-coupled overproduction.
Formal project proposal and Mutual NDA signing.
Employing CRISPR/Cas9 and multiplex integration to assemble pathways and silence competitive metabolic branches.
Customizing chassis selection between S. cerevisiae and Y. lipolytica.
Implementing directed evolution and colocalization (e.g., mitochondria targeting) to enhance non-native pathway kinetics.
Characterizing strains under industrial stress focusing on Titer, Yield, and Rate (TYR).
Final validation of the engineered microbial chassis in bioreactors to ensure commercial viability and genetic stability.
Comprehensive delivery of optimized strains, analytical data, and fermentation protocols.
To deliver world-class results, our technical team continuously monitors and benchmarks our protocols against landmark research in the field.
The transition from petroleum-based fuels requires robust microbial hosts. By integrating enzyme directed evolution and synthetic scaffolding, researchers engineered S. cerevisiae and Y. lipolytica to produce biobutanol and isoamyl alcohol. These strategies significantly improve metabolic flux for high-yield biofuel manufacturing.
(Reference: Liu et al., 2021)
Producing non-native products like opioids or complex terpenoids often suffers from intermediate loss. Colocalization strategies—such as mitochondrial engineering and artificial metabolons—direct metabolic flow with surgical precision. This approach has led to a dramatic increase in complex drug precursors, including cis-resveratrol.
(Reference: Yocum et al., 2021)
Low-molecular-weight (LMW) Hyaluronic Acid (HA) is highly sought after for superior skin permeability. By engineering the surface display of hyaluronidase on yeast cells, researchers converted high-MW HA into high-value LMW HA. This showcases yeast’s unique potential for direct biotransformation in the biomedical sector.
(Reference: Chen et al., 2023)
To maximize productivity, engineering must balance growth with product output. Utilizing Pareto-optimal metabolic engineering, researchers achieved "growth-coupled" overproduction of organic acids in yeast platforms. This ensuring high yields while maintaining the robust growth necessary for industrial-scale manufacturing.
(Reference: Amaradio et al., 2022)
Ready to engineer your customized microbial cell factory?
Contact Us1. Why use Yarrowia lipolytica instead of Saccharomyces cerevisiae?
While S. cerevisiae is the standard for ethanol, Y. lipolytica is often preferred for lipid-based chemicals, organic acids, and complex aromatics due to its unique metabolic flux and ability to handle hydrophobic substrates.
2. What is the benefit of "Growth-Coupled Overproduction"?
Growth-coupling ensures that the product is synthesized as a mandatory byproduct of cell growth. This prevents the "metabolic shift" during the stationary phase, leading to more stable and continuous industrial production.
3. How does enzyme colocalization improve target yield?
By artificially mimicking metabolons via mitochondria targeting or protein scaffolds, we reduce the distance intermediates must travel, preventing them from being consumed by competing pathways or reaching toxic levels.
4. Can you engineer yeast for food-grade applications?
Yes. We follow strict regulatory and safety protocols (such as GRAS standards) to develop strains suitable for the production of food ingredients, flavors, and nutritional additives.
5. What is the typical development cycle for a metabolic engineering project?
A standard comprehensive project—from network modeling and CRISPR assembly to Pareto optimization and validation—typically takes 16 to 22 weeks.
CRISPR-Cas9 technology represents a transformative advancement in gene editing techniques. The main function of the system is to precisely cut DNA sequences by combining guide RNA (gRNA) with the Cas9 protein. This technology became a mainstream genome editing tool quickly after its 2012 introduction because of its efficient, simple and low-cost nature.
The CRISPR gene editing system with its Cas9 version stands as a vital instrument for current biological research. CRISPR technology enables gene knockout (KO) through permanent gene expression blockage achieved by sequence disruption. Various scientific domains including disease modeling and drug screening employ this technology to study gene functions. CRISPR KO technology demonstrates high efficiency and precision but requires confirmation and verification post-implementation because unsatisfactory editing may produce off-target effects or incomplete gene knockouts which impact experimental result reliability. For precise and efficient Gene Editing Services - CD Biosynsis, Biosynsis offers comprehensive solutions tailored to your research needs.
The CRISPR-Cas9 knockout cell line was developed using CRISPR/Cas9 gene editing to allow scientists to remove genes accurately for research on gene function and disease models and pharmaceutical discovery. Genetic research considers this technology essential due to its high efficiency together with simple operation and broad usability.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.